CRISPR

CRISPR1-bcar1

ID
ZDB-CRISPR-210422-8
Name
CRISPR1-bcar1
Previous Names
None
Target
Sequence
5' - GTGCTGGAGCGGGACACGCA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
u7000 bcar1
Expression
Gene expression in Wild Types + CRISPR1-bcar1
No data available
Phenotype
Phenotype resulting from CRISPR1-bcar1
No data available
Phenotype of all Fish created by or utilizing CRISPR1-bcar1
Phenotype Fish Conditions Figures
whole organism decreased length, abnormal bcar1u7000/u7000 standard conditions Fig. S3 from Wisniewski et al., 2020
fin Ab1-bcar1 labeling absent, abnormal bcar1u7000/u7000 standard conditions Fig. S2 from Wisniewski et al., 2020
post-vent region Ab1-bcar1 labeling decreased distribution, abnormal bcar1u7000/u7000 standard conditions Fig. S2 from Wisniewski et al., 2020
whole organism Ab1-bcar1 labeling absent, abnormal bcar1u7000/u7000 standard conditions Fig. S2 from Wisniewski et al., 2020
post-vent region Ab1-bcar1 labeling decreased amount, abnormal bcar1u7000/u7000 standard conditions Fig. S2 from Wisniewski et al., 2020
trunk lymphangiogenesis decreased process quality, abnormal bcar1u7000/u7000; hu7135Tg; um13Tg standard conditions Fig. S5 from Wisniewski et al., 2020
caudal vein plexus angiogenesis decreased process quality, abnormal bcar1u7000/u7000; um13Tg; y7Tg standard conditions Figure 2 with image from Wisniewski et al., 2020
caudal vein plexus decreased area, abnormal bcar1u7000/u7000; um13Tg; y7Tg standard conditions Figure 2 with image from Wisniewski et al., 2020
caudal vein plexus structure, abnormal bcar1u7000/u7000; y1Tg chemical treatment: PP2 Figure 6 with image from Wisniewski et al., 2020
caudal vein plexus decreased area, abnormal bcar1u7000/u7000; y1Tg chemical treatment: SU6656 Figure 6 with image from Wisniewski et al., 2020
caudal vein plexus structure, abnormal bcar1u7000/u7000; y1Tg chemical treatment: SU6656 Figure 6 with image from Wisniewski et al., 2020
caudal vein plexus decreased area, abnormal bcar1u7000/u7000; y1Tg chemical treatment: PP2 Figure 6 with image from Wisniewski et al., 2020
caudal vein plexus structure, abnormal bcar1u7000/u7000; y1Tg control Figure 6 with image from Wisniewski et al., 2020
caudal vein plexus decreased area, abnormal bcar1u7000/u7000; y1Tg standard conditions Figure 2 with imageFigure 3 with imageFigure 6 with image from Wisniewski et al., 2020
caudal vein plexus angiogenesis decreased process quality, abnormal bcar1u7000/u7000; y1Tg standard conditions Figure 2 with image from Wisniewski et al., 2020
Citations